1-[1-(4-methoxyphenyl)-1H-pyrazol-4-yl]ethanone, 95.0%, 1g

3-Aminoquinolin-7-ol, 95.0%, 250mg

tert-Butyl 2-amino-4,5,7,8-tetrahydro-6H-thiazolo[4,5-d]azepine-6-carboxylate, 97%, 1g

2-(4-Aminophenyl)-1-(4-ethylpiperazin-1-yl)ethan-1-one, 98%, 1g

2-Amino-6-bromobenzoic acid, 97.0%, 1g

2,5-Dichloronicotinic acid, 97.0%, 25g

5-Chloro-2-nitro-4-(trifluoromethyl)aniline, 95.0%, 1g

Incubation shaker for microtiter plates, with tin-tight lid, 1 piece

(4-Methoxy-phenyl)-morpholin-4-yl-acetic acid; hydrochloride, 95.0%, 1g

2,6-Bis((S)-4-(tert-butyl)-4,5-dihydrooxazol-2-yl)pyridine, 95.0%, 5g

5-NITRO-3-(TRIFLUOROMETHYL)-1H-PYRROLO[2,3-B]PYRIDINE, 95.0%, 100mg

2?,3?,5?,6?-Tetrahydrospiro[2H-1-benzopyran-2,4?-[4H]pyran]-4(3H)-one, 98%, 250mg

1-(4-Propylphenyl)-2,5-di(2-thienyl)-1H-pyrrole>98.0%(GC)200mg